首页 › 肥胖症 › 密苏里州 › Kansas City
Kansas City MO 肥胖症临床试验
11项针对 肥胖症的研究正在 Kansas City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
招募中3 期
- Alliance for Multispecialty Research - Kansas City, Kansas City
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
招募中3 期
- Alliance for Multispecialty Research - Kansas City, Kansas City
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
招募中3 期
- Alliance for Multispecialty Research - Kansas City, Kansas City
- Kansas City Veterans Affairs Medical Center, Kansas City
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Kansas City
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
招募中3 期
- Research Site, Kansas City
- Research Site, Kansas City
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
招募中3 期
- Saint Luke's Hospital of Kansas City, Kansas City
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
招募中3 期
- Kansas City VA Medical Center, Kansas City
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Kansas City
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- Clinical Research Consultants, JCCT Co, Kansas City
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
招募中1 期
- MBX Biosciences Investigational Site, Kansas City
Social Determinants and a Diabetes Prevention Program Tailored for African Americans
招募中2 期欢迎健康志愿者
- University Health, Kansas City
- University of Missouri-Kansas City, Kansas City
其他城市的 肥胖症试验
- Houston, TX43 项研究
- Chicago, IL41 项研究
- New York City, NY40 项研究
- San Antonio, TX40 项研究
- Washington, DC33 项研究
- Orlando, FL32 项研究
- Dallas, TX30 项研究
- Boston, MA28 项研究
- Las Vegas, NV27 项研究
- Miami, FL27 项研究
- Baltimore, MD26 项研究
- Jacksonville, FL25 项研究
Kansas City的其他研究
- 乳腺癌34 项研究
- 非小细胞肺癌31 项研究
- 心力衰竭25 项研究
- 癌症（所有类型）21 项研究
- 肺癌19 项研究
- 结直肠癌16 项研究
- 转移性癌症15 项研究
- 急性髓系白血病15 项研究
- 前列腺癌14 项研究
- 卵巢癌11 项研究
- 2型糖尿病11 项研究
- 心血管疾病11 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。